BMPR2 and pulmonary arterial hypertension: Discovering a BMPR2 variant in PAH after defect closure reinforces the theses defending the use of genetics before considering the defect correction, as pathogenic variants in this gene have been associated with the development of pulmonary vascular disease in CHD [24,25].